Semaglutide is an antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management. It is a peptide similar to the hormone glucagon-like peptide-1, modified with a side chain. It can be administered by subcutaneous injection or taken orally.
ATC code: A10BJ06 (WHO)
Bioavailability: 89%
Duration of action: 63.6 h
Elimination half-life: 7 days
License data: US DailyMed: Semaglutide
Metabolism: Proteolysis